BridgeMD
New treatment option for CLASS II DIVISION 1 MALOCCLUSION
Official title EVALUATION OF TREATMENT CHANGES IN CLASS II DIVISION 1 MALOCCLUSION DURING EN MASSE RETRACTION OF UPPER ANTERIOR TEETH USING MINI IMPLANTS PLACED AT INFRAZYGOMATIC CREST AND INTERRADICULAR SITES A RANDOMIZED CLINICAL TRIAL.
ClinicalTrials.gov ID: NCT07405905
What this study is testing
- What it's testing
- Rationale: Class II Division 1 malocclusion is characterized by upper anterior teeth protrusion resulting in upper lip protrusion and convex facial profile, which are considered esthetically unfavorable. Treatment of class II malocclusion due to maxillary protrusion can be done with bilateral maxillary first premolar extraction followed by en-masse retraction of upper anterior teeth using mini-implants placed at infrazygomatic or interradicular sites.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Non growing patients
- Bilateral Class II molar relationship at pre-treatment.
- All permanent teeth upto the second molars should be present.
- No or minor crowding in the maxillary arch.
- Horizontal to average growth pattern.
You likely can't join if
- people with a history of fixed orthodontic treatment.
- Crossbite
- Vertical growth pattern
- Any systemic disease affecting bone and general growth
- Poor oral hygiene
- Cleft patients
See the full eligibility criteria
- Non growing patients
- Bilateral Class II molar relationship at pre-treatment.
- All permanent teeth upto the second molars should be present.
- No or minor crowding in the maxillary arch.
- Horizontal to average growth pattern.
- people with a history of fixed orthodontic treatment.
- Crossbite
- Vertical growth pattern
- Any systemic disease affecting bone and general growth
- Poor oral hygiene
- Cleft patients
- Patients who fail to follow up or undergo complete treatment
The study team makes the final eligibility decision.
Where it's taking place
- Rohtak, Haryana, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rohtak, Haryana, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.